Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
3rd Sep 20188:00 amRNSRe-admission of Phoenix Group Holdings
31st Aug 20185:45 pmRNSCompletion of Sale
31st Aug 20185:45 pmRNSCompletion of Standard Life Assurance Acquisition
31st Aug 20189:30 amRNSTotal Voting Rights
24th Aug 20184:15 pmRNSPublication of Suppl.Prospcts
23rd Aug 20184:46 pmRNSPublication of Suppl.Prospcts
23rd Aug 20187:00 amRNSHalf-year Report
10th Aug 20184:15 pmRNSHolding(s) in Company
10th Aug 20183:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSChairman Appointment
31st Jul 20184:45 pmRNSTotal Voting Rights
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSWarrant Redemption Notice
13th Jul 20183:40 pmRNSDirector/PDMR Shareholding
13th Jul 201811:00 amRNSHolding(s) in Company
12th Jul 201812:30 pmRNSTotal Voting Rights
11th Jul 20184:45 pmRNSTotal Voting Rights
10th Jul 201812:40 pmRNSResults of Rump Placing
10th Jul 20189:15 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSResults of Rights Issue
9th Jul 20182:45 pmRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
4th Jul 201812:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20182:00 pmRNSHolding(s) in Company
2nd Jul 201812:45 pmRNSDirector/PDMR Shareholding
29th Jun 201811:45 amRNSTotal Voting Rights
28th Jun 20183:00 pmRNSHolding(s) in Company
28th Jun 20183:00 pmRNSDirector/PDMR Shareholding
26th Jun 20188:06 amRNSAdmission of Nil Paid Rights
25th Jun 20181:45 pmRNSResults of General Meeting
25th Jun 20187:03 amRNSDirectorate Change
25th Jun 20187:00 amRNSBoard Changes
8th Jun 201810:15 amRNSDirector Declaration
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
6th Jun 20182:45 pmRNSHolding(s) in Company
31st May 20183:00 pmRNSTotal Voting Rights
30th May 201812:00 pmRNSPublication of Prospectus Circular & Notice of EGM
30th May 20187:00 amRNSLaunch of £950 million rights issue
22nd May 20189:59 amRNSPost Stabilisation Notice
21st May 201811:00 amRNSBlock Listing Application
11th May 20184:00 pmRNSDirector/PDMR Shareholding
10th May 20189:30 amRNSDirector Declaration
9th May 20182:46 pmRNSDirector/PDMR Shareholding
9th May 20182:45 pmRNSDirector/PDMR Shareholding
3rd May 201812:30 pmRNSUpdate on Standard Life Assurance Transaction
3rd May 201812:30 pmRNSUpdate on proposed transaction
2nd May 20183:30 pmRNSResult of AGM
2nd May 201810:19 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.